Boriani et al. (38) suggested the pathogenetic pathways, which start from activation of Erk 1/2 signaling leading to a profibrotic process, which encompasses transforming growth (TGF) beta 2-dependent activation of connective tissue growth factor, with the consequent progression of cardiomyopathy. This evidence concerns the gene CCN2 and cardiomyopathy.